First report of the successful use of bosentan in refractory vasospastic angina

Cardiology

Volumn 116, Issue 1, 2010, Pages 26-28

  Krishnan, Unni ^a   Win, Wutyee ^b   Fisher, Michael ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b Countess of Chester Hospital ^*  (United Kingdom)

Author keywords

Bosentan; Coronary vasospasm; Endothelin; Variant angina

Indexed keywords

ACETYLSALICYLIC ACID; BISOPROLOL; BOSENTAN; DILTIAZEM; DOXAZOSIN; GLYCERYL TRINITRATE; ISOSORBIDE MONONITRATE; NICORANDIL;

ADULT; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; DEFIBRILLATOR; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; EXERCISE TOLERANCE; FEMALE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAXIMUM TOLERATED DOSE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESUSCITATION; SINUS RHYTHM; THORAX PAIN; VARIANT ANGINA PECTORIS;

ANGINA PECTORIS, VARIANT; ANTIHYPERTENSIVE AGENTS; CORONARY VASOSPASM; ENDOTHELINS; FEMALE; HUMANS; MIDDLE AGED; SULFONAMIDES; TREATMENT OUTCOME;

EID: 77951233838     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313365     Document Type: Article

References (6)

1. Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS, Yanagisawa M, Masaki T, Sugimoto T: Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 1991; 83: 476-483.
2. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N: Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med 1959; 27: 375-388.
3. Halcox JP, Nour KR, Zalos G, Quyyumi AA: Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B. Hypertension 2007; 49: 1134-1141.
4. Dagassan PH, Clozel M, Breu V, Clozel JP: Role of endothelin in spontaneous phasic contraction of human coronary arteries. J Cardiovasc Pharmacol 1995; 26(suppl 3): S200-S203.
5. Wenzel RR, Fleisch M, Shaw S, Noll G, Kaufmann U, Schmitt R, Jones CR, Clozel M, Meier B, Lüscher TF: Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease. Circulation 1998; 98: 2235-2240.
6. Kolettis TM, Baltogiannis GG, Tsalikakis DG, Tzallas AT, Agelaki MG, Fotopoulos A, Fotiadis DI, Kyriakides ZS: Effects of dual endothelin receptor blockade on sympathetic activation and arrhythmogenesis during acute myocardial infarction in rats. Eur J Pharmacol 2008; 580: 241-249.